People news

Share this article:
Oscient Pharmaceuticals promoted Mark Glickman to SVP, sales and marketing and corporate officer. Glickman was VP sales and is credited with the growth of the company's lead product, Antara capsules. 

Nektar Therapeutics announced the appointment of Randall Moreadith, MD, PhD, to SVP, drug development and chief development officer. Moreadith will report to Nektar's president and CEO, Howard W. Robin.

Management consulting firm Campbell Alliance announced the appointment of Nader Naeymi-Rad as COO. Naeymi-Rad was formerly a SVP and head of the firm's brand management practice. Darius Naigamwalla has assumed that position.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.